Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyTreatment OutcomeCyclophosphamideMultiple MyelomaMelphalanTransplantation, HomologousTransplantation ConditioningSalvage TherapyLymphoma, Non-HodgkinAntineoplastic AgentsRemission InductionDisease-Free SurvivalStem CellsEtoposideHodgkin DiseaseCytarabineRecurrenceMyeloablative AgonistsSurvival RateCarmustineHematopoietic Stem Cell MobilizationBone Marrow TransplantationThiotepaSurvival AnalysisGraft vs Host DiseaseChemotherapy, AdjuvantDoxorubicinBone Marrow PurgingVincristineHematologic NeoplasmsWhole-Body IrradiationLymphoma, Mantle-CellPrognosisAmyloidosisRetrospective StudiesHematopoietic Stem CellsDexamethasoneBusulfanBoronic AcidsFollow-Up StudiesPyrazinesAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedGraft SurvivalIfosfamideLymphoma, FollicularInduction ChemotherapyAntigens, CD34Time FactorsLymphoma, T-Cell, PeripheralAutograftsThalidomideLiver TransplantationGranulocyte Colony-Stimulating FactorLymphomaLeukapheresisMesenchymal Stem Cell TransplantationCisplatinPodophyllotoxinPrednisoneNeoplasm, ResidualMaintenance ChemotherapyLymphoma, Large B-Cell, DiffuseDose-Response Relationship, DrugTransplantation ChimeraLeukemia, Myeloid, AcuteTissue DonorsCarboplatinDrug Administration ScheduleCord Blood Stem Cell TransplantationMitoxantroneCell TransplantationLymphoma, B-CellProspective StudiesIdarubicinNeoplasm Recurrence, LocalKidney TransplantationMyelodysplastic SyndromesNeoplasms, Second PrimaryEnteropathy-Associated T-Cell LymphomaEmbryonic Stem CellsLeukemia, Plasma CellInfusions, SpinalAntibodies, MonoclonalNeoplasm StagingBlood Component RemovalImmunosuppressive AgentsBreast NeoplasmsFeasibility StudiesAdult Stem CellsNeutropeniaNeoplasmsLeukemia, MyeloidHistocompatibility TestingFatal Outcome